Today
Today
No intelligence items published yet.
Healthcare · Drug Manufacturers - General · NYSE
Forecast withheld
stale data
AbbVie Inc.
Value
Model value 54% below price
Estimate momentum
→ stable
Next catalyst
none scheduled
Volatility
normal
regime
1M forecast
withheld
Value tells you the size of the gap; the other cells tell you what could close it — and when. A cheap stock without a catalyst can stay cheap.
Estimated fair value
135.45
Range
75.97–211.38
Model value vs price
54% below price
Model value is 54% below price. Compare the individual methods below; a valuation gap is not a timing signal.
Forward earnings lens
21.2x FY2026 P/E
EPS 13.91+489.5%16 analystsreported FY2025
Consensus earnings estimates are shown separately from the valuation models.
Where estimates sit vs price 294.89
Cheap or expensive — depending on the yardstick
Entry threshold
below 108.36(fair value 135.45 − 20%)
price is 172% above your threshold
A valuation threshold, not a timing signal — a cheap stock can keep falling. Alerts wire in when the notification substrate lands.
→ Estimates stable (revenue -0.0% · EPS -1.0% · targets +2.4% this month)
Company profile at a glance
Bars are scaled to documented anchors (e.g. 35% operating margin = full bar), not ranked against other companies. Each row stands on its own — there is no hidden total score.
Financials at a glance· latest reported year · 13y of statements
Revenue
$61.2B
+9% per year over the period
Operating margin
24.6%
5y average 25.5%
Free cash flow
$17.8B
29.1% of revenue
Net debt / EBITDA
3.6×
ROE
-129.2%
net income ÷ equity
ROIC
19.7%
after-tax operating profit ÷ capital
Dividends paid
$11.7B
latest year
Buybacks
$980M
share repurchases, latest year
Where the revenue dollar went · FY2025
What the current price is assuming
Each solve varies one assumption while holding the other cash-flow assumptions fixed.
What the DCF is made of — present value by year (base case)
Terminal value is 65% of the total. Solid years are consensus-anchored; lighter years fade to the stable rate.
Which growth × margin combinations justify today's price
| margin ↓ / growth → | -5% | 0% | 5% | 10% | 15% | 20% | 25% | 30% | 35% | 40% |
|---|---|---|---|---|---|---|---|---|---|---|
| 60% | ||||||||||
| 55% | ||||||||||
| 50% | ||||||||||
| 45% | ||||||||||
| 40% | ||||||||||
| 35% | ||||||||||
| 30% | ||||||||||
| 25% | ||||||||||
| 20% | ||||||||||
| 15% | ||||||||||
| 10% | ||||||||||
| 5% | ||||||||||
| 0% |
Sage cells are the assumption pairs that make the model value equal today's price (±2%) — none inside these bounds — the price asks for more than this grid allows.
Price vs fair value through time
— price · — fair value (band = bear–bull). Vintages accumulating since 2026-08-14 (recorded at compute time; no historical backfill).
Fair value if assumptions move — discount rate × terminal growth
| discount rate ↓ | g 0% | g 1% | g 2% | g 3% | g 4% |
|---|---|---|---|---|---|
| 6.5% | 110.25 | 123.2 | 141.85 | 171.01 | 223.09 |
| 7.0% | 98.05 | 108.32 | 122.66 | 144.09 | 179.59 |
| 7.5% | 87.51 | 95.75 | 106.96 | 123.1 | 148.34 |
| 8.0% | 78.32 | 84.99 | 93.87 | 106.27 | 124.79 |
| 8.5% | 70.24 | 75.69 | 82.8 | 92.48 | 106.41 |
| 9.0% | 63.08 | 67.56 | 73.32 | 80.97 | 91.66 |
| 9.5% | 56.7 | 60.41 | 65.1 | 71.23 | 79.56 |
Cells compare each implied fair value with the current price 294.89: green above it, burgundy below. Outlined cell = base case.
66 candles · 3M · retrieved